| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dog Diseases | 34 | 2025 | 48 | 5.940 |
Why?
|
| Cat Diseases | 21 | 2024 | 25 | 3.160 |
Why?
|
| Animals | 159 | 2025 | 16695 | 2.000 |
Why?
|
| Dogs | 38 | 2025 | 201 | 1.980 |
Why?
|
| Cattle Diseases | 11 | 2024 | 30 | 1.710 |
Why?
|
| Chlamydia Infections | 17 | 2021 | 199 | 1.590 |
Why?
|
| Acinetobacter baumannii | 7 | 2022 | 35 | 1.580 |
Why?
|
| Skin Neoplasms | 11 | 2023 | 175 | 1.350 |
Why?
|
| Brain | 19 | 2025 | 1452 | 1.320 |
Why?
|
| Carcinoma, Squamous Cell | 9 | 2023 | 187 | 1.270 |
Why?
|
| Chlamydia muridarum | 14 | 2021 | 104 | 1.220 |
Why?
|
| Cats | 24 | 2024 | 80 | 1.160 |
Why?
|
| Neurofibrillary Tangles | 6 | 2024 | 113 | 1.110 |
Why?
|
| Disease Models, Animal | 19 | 2024 | 1554 | 1.100 |
Why?
|
| tau Proteins | 9 | 2024 | 182 | 1.050 |
Why?
|
| Francisella tularensis | 9 | 2016 | 116 | 1.040 |
Why?
|
| Papillomavirus Infections | 11 | 2021 | 363 | 1.030 |
Why?
|
| Hedgehogs | 3 | 2021 | 4 | 0.920 |
Why?
|
| Lymphoma, T-Cell | 5 | 2023 | 29 | 0.890 |
Why?
|
| Glucans | 3 | 2021 | 8 | 0.890 |
Why?
|
| Papillomaviridae | 9 | 2023 | 136 | 0.880 |
Why?
|
| Alzheimer Disease | 9 | 2024 | 972 | 0.870 |
Why?
|
| Tularemia | 10 | 2018 | 115 | 0.840 |
Why?
|
| Histiocytic Sarcoma | 5 | 2023 | 5 | 0.830 |
Why?
|
| Macrophages | 15 | 2021 | 515 | 0.820 |
Why?
|
| Mast Cells | 8 | 2021 | 83 | 0.800 |
Why?
|
| Tauopathies | 5 | 2024 | 22 | 0.800 |
Why?
|
| Immunohistochemistry | 14 | 2025 | 928 | 0.770 |
Why?
|
| Aging | 6 | 2021 | 764 | 0.760 |
Why?
|
| Female | 68 | 2025 | 24018 | 0.750 |
Why?
|
| Mice | 47 | 2025 | 6490 | 0.740 |
Why?
|
| Recombinant Proteins | 6 | 2021 | 522 | 0.720 |
Why?
|
| Acid Phosphatase | 1 | 2021 | 23 | 0.710 |
Why?
|
| Virulence Factors | 6 | 2021 | 119 | 0.710 |
Why?
|
| Bacterial Vaccines | 9 | 2017 | 129 | 0.700 |
Why?
|
| alpha-Synuclein | 4 | 2024 | 59 | 0.690 |
Why?
|
| Enzootic Bovine Leukosis | 4 | 2024 | 5 | 0.690 |
Why?
|
| Papilloma | 5 | 2020 | 17 | 0.650 |
Why?
|
| Proteome | 1 | 2021 | 150 | 0.640 |
Why?
|
| Leukemia Virus, Bovine | 3 | 2024 | 4 | 0.630 |
Why?
|
| Bordetella Infections | 1 | 2019 | 1 | 0.610 |
Why?
|
| Bronchopneumonia | 1 | 2019 | 2 | 0.610 |
Why?
|
| Thioredoxins | 4 | 2021 | 36 | 0.600 |
Why?
|
| Japan | 15 | 2024 | 348 | 0.600 |
Why?
|
| Male | 48 | 2025 | 22779 | 0.570 |
Why?
|
| Influenza A virus | 2 | 2009 | 31 | 0.570 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2018 | 1 | 0.570 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2018 | 1 | 0.570 |
Why?
|
| Lafora Disease | 1 | 2018 | 1 | 0.570 |
Why?
|
| Cattle | 14 | 2024 | 505 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 25 | 2022 | 1804 | 0.570 |
Why?
|
| Polyps | 1 | 2018 | 9 | 0.570 |
Why?
|
| Insurance Coverage | 2 | 2019 | 108 | 0.560 |
Why?
|
| Neurons | 7 | 2024 | 1246 | 0.560 |
Why?
|
| Biopharmaceutics | 1 | 2017 | 2 | 0.560 |
Why?
|
| Health Care Sector | 1 | 2017 | 10 | 0.560 |
Why?
|
| DNA, Viral | 8 | 2021 | 323 | 0.560 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 658 | 0.550 |
Why?
|
| Horse Diseases | 4 | 2022 | 11 | 0.540 |
Why?
|
| Receptors, Cell Surface | 7 | 2010 | 146 | 0.540 |
Why?
|
| B-Lymphocytes | 6 | 2024 | 183 | 0.540 |
Why?
|
| Health Care Costs | 1 | 2017 | 89 | 0.530 |
Why?
|
| Uterine Neoplasms | 1 | 2018 | 51 | 0.520 |
Why?
|
| Endometrial Neoplasms | 1 | 2018 | 79 | 0.520 |
Why?
|
| Bacterial Proteins | 10 | 2019 | 580 | 0.520 |
Why?
|
| Antigens, Bacterial | 7 | 2018 | 144 | 0.510 |
Why?
|
| Insurance, Health | 1 | 2017 | 143 | 0.510 |
Why?
|
| GTP-Binding Proteins | 4 | 2017 | 58 | 0.510 |
Why?
|
| Gallbladder | 3 | 2025 | 5 | 0.510 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 287 | 0.500 |
Why?
|
| Health Policy | 1 | 2017 | 184 | 0.490 |
Why?
|
| Interferon-gamma | 12 | 2023 | 268 | 0.470 |
Why?
|
| Mucocele | 2 | 2025 | 3 | 0.470 |
Why?
|
| Gallbladder Diseases | 2 | 2025 | 5 | 0.470 |
Why?
|
| Bovine papillomavirus 1 | 3 | 2019 | 4 | 0.460 |
Why?
|
| MicroRNAs | 5 | 2021 | 501 | 0.450 |
Why?
|
| Neoplasms, Experimental | 3 | 2019 | 38 | 0.450 |
Why?
|
| Paresis | 2 | 2024 | 12 | 0.440 |
Why?
|
| Brachial Plexus | 1 | 2014 | 3 | 0.440 |
Why?
|
| Gastrointestinal Tract | 2 | 2018 | 67 | 0.430 |
Why?
|
| Humans | 55 | 2025 | 42163 | 0.430 |
Why?
|
| Animals, Wild | 2 | 2020 | 24 | 0.430 |
Why?
|
| Epitopes | 2 | 2024 | 155 | 0.420 |
Why?
|
| Genome, Viral | 5 | 2021 | 118 | 0.420 |
Why?
|
| Helicobacter Infections | 3 | 2021 | 84 | 0.420 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2019 | 84 | 0.410 |
Why?
|
| Lymphoma, B-Cell | 3 | 2024 | 28 | 0.410 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2022 | 17 | 0.400 |
Why?
|
| Polymerase Chain Reaction | 7 | 2024 | 454 | 0.400 |
Why?
|
| Stomach Neoplasms | 3 | 2021 | 228 | 0.400 |
Why?
|
| STAT3 Transcription Factor | 2 | 2024 | 97 | 0.400 |
Why?
|
| Military Personnel | 1 | 2014 | 109 | 0.390 |
Why?
|
| Amino Acid Sequence | 12 | 2025 | 1188 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2017 | 649 | 0.380 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2011 | 7 | 0.370 |
Why?
|
| Military Medicine | 1 | 2011 | 9 | 0.360 |
Why?
|
| Microscopy | 2 | 2021 | 33 | 0.360 |
Why?
|
| Acinetobacter Infections | 4 | 2021 | 24 | 0.360 |
Why?
|
| Internationality | 1 | 2011 | 38 | 0.360 |
Why?
|
| Propolis | 2 | 2022 | 6 | 0.360 |
Why?
|
| Cloaca | 1 | 2011 | 4 | 0.360 |
Why?
|
| Orthomyxoviridae | 1 | 2011 | 5 | 0.360 |
Why?
|
| Microscopy, Fluorescence | 3 | 2021 | 254 | 0.360 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2011 | 15 | 0.350 |
Why?
|
| Lung | 6 | 2021 | 484 | 0.350 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 150 | 0.350 |
Why?
|
| Immunoglobulin A | 5 | 2022 | 63 | 0.350 |
Why?
|
| RNA, Messenger | 9 | 2019 | 1265 | 0.350 |
Why?
|
| Ducks | 1 | 2011 | 29 | 0.340 |
Why?
|
| Herpesvirus 1, Human | 2 | 2014 | 64 | 0.340 |
Why?
|
| Epithelial Cells | 3 | 2025 | 426 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 3 | 2020 | 382 | 0.330 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 129 | 0.330 |
Why?
|
| Peptide Fragments | 4 | 2022 | 301 | 0.330 |
Why?
|
| Skin | 6 | 2021 | 185 | 0.330 |
Why?
|
| Mice, Knockout | 14 | 2021 | 1010 | 0.320 |
Why?
|
| Intestinal Neoplasms | 3 | 2023 | 6 | 0.320 |
Why?
|
| Genital Diseases, Female | 4 | 2013 | 38 | 0.320 |
Why?
|
| Influenza in Birds | 1 | 2009 | 11 | 0.310 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 250 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 2 | 2021 | 74 | 0.310 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2019 | 22 | 0.300 |
Why?
|
| Swine Diseases | 2 | 2019 | 9 | 0.300 |
Why?
|
| Phagocytosis | 3 | 2019 | 83 | 0.300 |
Why?
|
| Swine | 4 | 2020 | 205 | 0.290 |
Why?
|
| Chickens | 1 | 2009 | 148 | 0.290 |
Why?
|
| Spleen | 10 | 2020 | 199 | 0.290 |
Why?
|
| Drosophila Proteins | 2 | 2020 | 183 | 0.280 |
Why?
|
| Autopsy | 3 | 2022 | 46 | 0.280 |
Why?
|
| Leishmania donovani | 2 | 2019 | 18 | 0.280 |
Why?
|
| Bacteria | 1 | 2011 | 285 | 0.280 |
Why?
|
| Receptors, Purinergic P2 | 3 | 2002 | 15 | 0.280 |
Why?
|
| Adenoma | 2 | 2019 | 94 | 0.280 |
Why?
|
| Antibodies, Bacterial | 6 | 2017 | 117 | 0.280 |
Why?
|
| Immunity, Innate | 4 | 2018 | 168 | 0.270 |
Why?
|
| Influenza B virus | 1 | 2007 | 5 | 0.270 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2020 | 160 | 0.270 |
Why?
|
| Helicobacter | 2 | 2017 | 3 | 0.270 |
Why?
|
| Genitalia, Female | 4 | 2014 | 29 | 0.270 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2001 | 88 | 0.270 |
Why?
|
| Enteritis | 2 | 2017 | 6 | 0.270 |
Why?
|
| Cell Line | 12 | 2025 | 1416 | 0.260 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2021 | 58 | 0.260 |
Why?
|
| Biosensing Techniques | 2 | 2008 | 130 | 0.260 |
Why?
|
| Liver | 6 | 2020 | 503 | 0.250 |
Why?
|
| Interleukin-4 | 5 | 2018 | 75 | 0.240 |
Why?
|
| Herpesvirus 2, Human | 1 | 2005 | 9 | 0.240 |
Why?
|
| Serum Amyloid A Protein | 2 | 2016 | 14 | 0.240 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2016 | 15 | 0.240 |
Why?
|
| Neuropeptides | 3 | 2000 | 63 | 0.240 |
Why?
|
| Base Sequence | 8 | 2015 | 997 | 0.240 |
Why?
|
| Sea Lions | 2 | 2022 | 3 | 0.240 |
Why?
|
| Receptors, IgE | 3 | 2016 | 22 | 0.240 |
Why?
|
| Felidae | 1 | 2025 | 4 | 0.240 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2005 | 33 | 0.240 |
Why?
|
| Antibodies, Monoclonal | 2 | 2024 | 301 | 0.240 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2005 | 40 | 0.240 |
Why?
|
| Software | 3 | 2021 | 234 | 0.240 |
Why?
|
| Amyloidosis | 2 | 2016 | 38 | 0.230 |
Why?
|
| Coronavirus | 1 | 2025 | 9 | 0.230 |
Why?
|
| Specimen Handling | 1 | 2005 | 61 | 0.230 |
Why?
|
| Endopeptidases | 3 | 2016 | 63 | 0.230 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 1066 | 0.230 |
Why?
|
| Microscopy, Confocal | 3 | 2021 | 223 | 0.230 |
Why?
|
| Sarcoma | 1 | 2025 | 11 | 0.230 |
Why?
|
| Organoids | 1 | 2025 | 33 | 0.230 |
Why?
|
| Chiroptera | 1 | 2025 | 23 | 0.230 |
Why?
|
| Calcification, Physiologic | 1 | 2025 | 18 | 0.230 |
Why?
|
| Bacterial Adhesion | 2 | 2018 | 40 | 0.230 |
Why?
|
| Mutation | 4 | 2024 | 1169 | 0.230 |
Why?
|
| Virus Internalization | 1 | 2025 | 36 | 0.230 |
Why?
|
| Immunization | 5 | 2024 | 93 | 0.230 |
Why?
|
| Cytokines | 4 | 2023 | 661 | 0.230 |
Why?
|
| Paper | 1 | 2025 | 24 | 0.230 |
Why?
|
| Phagosomes | 2 | 2018 | 33 | 0.220 |
Why?
|
| Spinal Canal | 1 | 2024 | 1 | 0.220 |
Why?
|
| Abscess | 1 | 2024 | 10 | 0.220 |
Why?
|
| Goat Diseases | 1 | 2024 | 5 | 0.220 |
Why?
|
| Goats | 1 | 2024 | 22 | 0.220 |
Why?
|
| Granzymes | 4 | 2023 | 19 | 0.220 |
Why?
|
| Leptospira | 1 | 2024 | 27 | 0.220 |
Why?
|
| Borrelia burgdorferi | 2 | 2017 | 25 | 0.220 |
Why?
|
| Exophiala | 1 | 2024 | 2 | 0.220 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 1559 | 0.220 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2024 | 23 | 0.220 |
Why?
|
| Leptospirosis | 1 | 2024 | 30 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 10 | 2019 | 686 | 0.220 |
Why?
|
| Hantavirus Infections | 1 | 2024 | 35 | 0.220 |
Why?
|
| Prognosis | 6 | 2023 | 850 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2021 | 385 | 0.220 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 21 | 0.220 |
Why?
|
| Histiocytes | 2 | 2021 | 2 | 0.210 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 37 | 0.210 |
Why?
|
| Cytoplasm | 1 | 2024 | 154 | 0.210 |
Why?
|
| Bone and Bones | 1 | 2025 | 115 | 0.210 |
Why?
|
| RNA Interference | 1 | 2025 | 246 | 0.210 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2023 | 3 | 0.210 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2025 | 82 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 94 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2025 | 81 | 0.210 |
Why?
|
| Transfection | 4 | 2018 | 526 | 0.210 |
Why?
|
| STAT1 Transcription Factor | 1 | 2023 | 35 | 0.210 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 11 | 0.200 |
Why?
|
| History, Ancient | 2 | 2014 | 15 | 0.200 |
Why?
|
| Cyclin B1 | 2 | 2020 | 18 | 0.200 |
Why?
|
| CDC2 Protein Kinase | 2 | 2020 | 20 | 0.200 |
Why?
|
| Neurosurgery | 1 | 2022 | 4 | 0.200 |
Why?
|
| History, 21st Century | 2 | 2014 | 85 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 203 | 0.200 |
Why?
|
| Helicobacter pylori | 2 | 2021 | 116 | 0.190 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 557 | 0.190 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 683 | 0.190 |
Why?
|
| History, 20th Century | 2 | 2014 | 124 | 0.190 |
Why?
|
| Treatment Outcome | 4 | 2021 | 1586 | 0.190 |
Why?
|
| Hippocampus | 3 | 2022 | 591 | 0.190 |
Why?
|
| Rats | 10 | 2024 | 3701 | 0.190 |
Why?
|
| Cross Infection | 1 | 2022 | 47 | 0.190 |
Why?
|
| Epilepsy | 1 | 2022 | 56 | 0.190 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 26 | 0.190 |
Why?
|
| Animals, Newborn | 3 | 2019 | 350 | 0.180 |
Why?
|
| HLA-DR4 Antigen | 2 | 2013 | 20 | 0.180 |
Why?
|
| Signal Transduction | 7 | 2024 | 2111 | 0.180 |
Why?
|
| Programming Languages | 1 | 2021 | 29 | 0.180 |
Why?
|
| Protein Phosphatase 2 | 1 | 2021 | 25 | 0.180 |
Why?
|
| Receptors, Corticotropin | 1 | 2001 | 4 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 101 | 0.180 |
Why?
|
| Marsupialia | 1 | 2021 | 6 | 0.180 |
Why?
|
| Euglena gracilis | 1 | 2021 | 1 | 0.180 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2021 | 3 | 0.180 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2021 | 18 | 0.180 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2001 | 27 | 0.180 |
Why?
|
| Cells, Cultured | 11 | 2016 | 1617 | 0.180 |
Why?
|
| Sequence Homology | 1 | 2021 | 34 | 0.180 |
Why?
|
| Stem Cells | 2 | 2018 | 151 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2016 | 276 | 0.180 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2019 | 168 | 0.180 |
Why?
|
| Kinetics | 3 | 2021 | 698 | 0.180 |
Why?
|
| Hydrolysis | 1 | 2021 | 98 | 0.180 |
Why?
|
| Molecular Weight | 1 | 2021 | 168 | 0.170 |
Why?
|
| Mastocytosis, Cutaneous | 1 | 2020 | 2 | 0.170 |
Why?
|
| Horses | 4 | 2022 | 28 | 0.170 |
Why?
|
| Spinal Cord | 1 | 2021 | 109 | 0.170 |
Why?
|
| Xipapillomavirus | 1 | 2020 | 1 | 0.170 |
Why?
|
| Vulva | 1 | 2020 | 3 | 0.170 |
Why?
|
| Cesium Radioisotopes | 1 | 2020 | 1 | 0.170 |
Why?
|
| Food Contamination, Radioactive | 1 | 2020 | 1 | 0.170 |
Why?
|
| Substrate Specificity | 1 | 2021 | 217 | 0.170 |
Why?
|
| Dendritic Cells | 2 | 2020 | 130 | 0.170 |
Why?
|
| Langerhans Cells | 1 | 2020 | 2 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2020 | 271 | 0.170 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 94 | 0.170 |
Why?
|
| Kidney | 5 | 2024 | 363 | 0.170 |
Why?
|
| Niemann-Pick Diseases | 1 | 2020 | 3 | 0.170 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2000 | 24 | 0.170 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2020 | 9 | 0.170 |
Why?
|
| Sepsis | 3 | 2018 | 90 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 508 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2002 | 548 | 0.160 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2019 | 17 | 0.160 |
Why?
|
| Eating | 1 | 2001 | 164 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2019 | 2 | 0.160 |
Why?
|
| Genitalia | 2 | 2016 | 18 | 0.160 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2019 | 2 | 0.160 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 57 | 0.160 |
Why?
|
| Gallbladder Neoplasms | 1 | 2019 | 3 | 0.160 |
Why?
|
| Cholecystitis | 1 | 2019 | 7 | 0.160 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 13 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 114 | 0.160 |
Why?
|
| Anaphase | 1 | 2019 | 7 | 0.160 |
Why?
|
| Caspase 1 | 2 | 2016 | 16 | 0.160 |
Why?
|
| Neoplasms | 2 | 2022 | 1341 | 0.160 |
Why?
|
| Urothelium | 1 | 2019 | 8 | 0.160 |
Why?
|
| Vulvar Neoplasms | 1 | 2019 | 10 | 0.160 |
Why?
|
| Protein Conformation | 1 | 2020 | 420 | 0.160 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2019 | 3 | 0.150 |
Why?
|
| Limbic Encephalitis | 1 | 2019 | 2 | 0.150 |
Why?
|
| Quality of Life | 3 | 2022 | 599 | 0.150 |
Why?
|
| Bowen's Disease | 1 | 2019 | 4 | 0.150 |
Why?
|
| Parapoxvirus | 1 | 2019 | 1 | 0.150 |
Why?
|
| Tongue Diseases | 1 | 2019 | 2 | 0.150 |
Why?
|
| Poxviridae Infections | 1 | 2019 | 3 | 0.150 |
Why?
|
| Fimbriae, Bacterial | 1 | 2019 | 26 | 0.150 |
Why?
|
| Erythrocytes | 2 | 2019 | 126 | 0.150 |
Why?
|
| Bordetella bronchiseptica | 1 | 2019 | 1 | 0.150 |
Why?
|
| Vaccines, Attenuated | 3 | 2017 | 75 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 35 | 0.150 |
Why?
|
| Medical Oncology | 1 | 2019 | 46 | 0.150 |
Why?
|
| Calcium Channels | 2 | 2000 | 74 | 0.150 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 72 | 0.150 |
Why?
|
| Necrosis | 1 | 2019 | 54 | 0.150 |
Why?
|
| Chlamydia trachomatis | 2 | 2016 | 69 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 107 | 0.150 |
Why?
|
| Neutrophils | 4 | 2015 | 141 | 0.150 |
Why?
|
| Anus Neoplasms | 1 | 2019 | 43 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 64 | 0.150 |
Why?
|
| Mastocytoma, Skin | 1 | 2018 | 1 | 0.150 |
Why?
|
| Mastocytosis | 1 | 2018 | 3 | 0.150 |
Why?
|
| Stem Cell Factor | 1 | 2018 | 7 | 0.150 |
Why?
|
| Keratins | 1 | 2018 | 25 | 0.150 |
Why?
|
| Oligodendroglioma | 1 | 2018 | 6 | 0.150 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2018 | 16 | 0.150 |
Why?
|
| Phylogeny | 5 | 2023 | 740 | 0.150 |
Why?
|
| Adrenal Medulla | 1 | 2018 | 15 | 0.140 |
Why?
|
| Astrocytes | 2 | 2018 | 244 | 0.140 |
Why?
|
| Pheochromocytoma | 1 | 2018 | 12 | 0.140 |
Why?
|
| Nerve Growth Factors | 1 | 1998 | 34 | 0.140 |
Why?
|
| Seaweed | 1 | 2018 | 12 | 0.140 |
Why?
|
| Oligodendroglia | 1 | 2018 | 27 | 0.140 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2018 | 19 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2018 | 50 | 0.140 |
Why?
|
| Glycogen | 1 | 2018 | 20 | 0.140 |
Why?
|
| Inclusion Bodies | 1 | 2018 | 34 | 0.140 |
Why?
|
| Dyneins | 1 | 1997 | 8 | 0.140 |
Why?
|
| Cost Savings | 1 | 2017 | 18 | 0.140 |
Why?
|
| Drug Costs | 1 | 2017 | 36 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2018 | 44 | 0.140 |
Why?
|
| Models, Economic | 1 | 2017 | 30 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2019 | 137 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 48 | 0.140 |
Why?
|
| Cognition Disorders | 1 | 2019 | 243 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 68 | 0.140 |
Why?
|
| Disease Outbreaks | 1 | 2019 | 169 | 0.140 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2017 | 76 | 0.140 |
Why?
|
| Phosphorylation | 4 | 2024 | 973 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 84 | 0.140 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 90 | 0.140 |
Why?
|
| Helicobacter heilmannii | 1 | 2017 | 1 | 0.140 |
Why?
|
| Ubiquitin | 1 | 2018 | 80 | 0.140 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 149 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2017 | 13 | 0.140 |
Why?
|
| Leukemia Virus, Feline | 1 | 2017 | 1 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 1997 | 140 | 0.130 |
Why?
|
| Tissue Fixation | 1 | 2017 | 18 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 77 | 0.130 |
Why?
|
| Colonic Polyps | 1 | 2018 | 70 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 22 | 0.130 |
Why?
|
| Gliadin | 1 | 2017 | 3 | 0.130 |
Why?
|
| Phenotype | 2 | 2018 | 774 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2017 | 22 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2017 | 13 | 0.130 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2017 | 1 | 0.130 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2017 | 1 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 115 | 0.130 |
Why?
|
| Endometrium | 1 | 2018 | 60 | 0.130 |
Why?
|
| Transglutaminases | 1 | 2017 | 7 | 0.130 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 164 | 0.130 |
Why?
|
| Intestines | 4 | 2020 | 71 | 0.130 |
Why?
|
| Spermidine | 1 | 2017 | 34 | 0.130 |
Why?
|
| Lymphoma | 1 | 2017 | 38 | 0.130 |
Why?
|
| Interleukin-12 | 3 | 2016 | 46 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 176 | 0.130 |
Why?
|
| Vaccination | 3 | 2014 | 332 | 0.130 |
Why?
|
| Autophagy | 1 | 2018 | 136 | 0.130 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2016 | 12 | 0.130 |
Why?
|
| Thogotovirus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 233 | 0.130 |
Why?
|
| Immunoglobulin G | 4 | 2022 | 253 | 0.130 |
Why?
|
| Coculture Techniques | 5 | 2016 | 105 | 0.130 |
Why?
|
| Spermine | 1 | 2017 | 65 | 0.130 |
Why?
|
| DNA Primers | 3 | 2013 | 295 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 51 | 0.130 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 14 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2017 | 88 | 0.130 |
Why?
|
| Animals, Laboratory | 1 | 2016 | 3 | 0.120 |
Why?
|
| Animals, Domestic | 1 | 2016 | 11 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2010 | 205 | 0.120 |
Why?
|
| Ferrets | 1 | 2016 | 14 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2023 | 541 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2016 | 534 | 0.120 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 2598 | 0.120 |
Why?
|
| Proteins | 2 | 2013 | 383 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 36 | 0.120 |
Why?
|
| Bunyaviridae Infections | 1 | 2015 | 7 | 0.120 |
Why?
|
| Orthobunyavirus | 1 | 2015 | 5 | 0.120 |
Why?
|
| Nematode Infections | 1 | 2015 | 2 | 0.120 |
Why?
|
| Nematoda | 1 | 2015 | 11 | 0.120 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2015 | 7 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 58 | 0.120 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2015 | 4 | 0.120 |
Why?
|
| beta Catenin | 3 | 2022 | 75 | 0.110 |
Why?
|
| Bone Marrow Cells | 2 | 2012 | 79 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 28 | 0.110 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 158 | 0.110 |
Why?
|
| Fatal Outcome | 3 | 2021 | 46 | 0.110 |
Why?
|
| Monkey Diseases | 1 | 2014 | 6 | 0.110 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 318 | 0.110 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2015 | 30 | 0.110 |
Why?
|
| Callithrix | 1 | 2014 | 12 | 0.110 |
Why?
|
| Herpesviridae Infections | 1 | 2014 | 18 | 0.110 |
Why?
|
| Logistic Models | 1 | 2017 | 1001 | 0.110 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 25 | 0.110 |
Why?
|
| Zoonoses | 1 | 2014 | 20 | 0.110 |
Why?
|
| Nerve Transfer | 1 | 2014 | 1 | 0.110 |
Why?
|
| Tendon Transfer | 1 | 2014 | 2 | 0.110 |
Why?
|
| Time | 1 | 2014 | 16 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2014 | 19 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 138 | 0.110 |
Why?
|
| Virulence | 2 | 2011 | 238 | 0.110 |
Why?
|
| Inflammation | 1 | 2019 | 729 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2014 | 34 | 0.110 |
Why?
|
| Proteomics | 2 | 2013 | 363 | 0.110 |
Why?
|
| Aptamers, Peptide | 1 | 2013 | 6 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 1058 | 0.110 |
Why?
|
| Lysosomes | 1 | 2014 | 88 | 0.100 |
Why?
|
| Administration, Oral | 3 | 2021 | 256 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2017 | 456 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 379 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 100 | 0.100 |
Why?
|
| Birds | 2 | 2011 | 93 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2015 | 452 | 0.100 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 59 | 0.100 |
Why?
|
| Hindlimb | 2 | 2024 | 32 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 72 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2019 | 884 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 39 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2020 | 2485 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 3 | 2018 | 14 | 0.100 |
Why?
|
| Metaplasia | 2 | 2025 | 39 | 0.100 |
Why?
|
| Caspase 3 | 3 | 2023 | 226 | 0.100 |
Why?
|
| Mevalonic Acid | 1 | 2012 | 9 | 0.100 |
Why?
|
| Perforin | 1 | 2012 | 11 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 502 | 0.090 |
Why?
|
| Formaldehyde | 2 | 2017 | 30 | 0.090 |
Why?
|
| Mucous Membrane | 1 | 2012 | 34 | 0.090 |
Why?
|
| Acetates | 1 | 2012 | 29 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 933 | 0.090 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2011 | 3 | 0.090 |
Why?
|
| Amyloidosis, Familial | 1 | 2011 | 1 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 29 | 0.090 |
Why?
|
| Haptoglobins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Leukocyte Elastase | 1 | 2011 | 12 | 0.090 |
Why?
|
| Capillaria | 1 | 2011 | 1 | 0.090 |
Why?
|
| Enoplida Infections | 1 | 2011 | 1 | 0.090 |
Why?
|
| Prealbumin | 1 | 2011 | 8 | 0.090 |
Why?
|
| Cryoglobulinemia | 1 | 2011 | 3 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2018 | 196 | 0.090 |
Why?
|
| United States | 2 | 2014 | 5072 | 0.090 |
Why?
|
| Quality Control | 2 | 2021 | 41 | 0.090 |
Why?
|
| History, 16th Century | 1 | 2011 | 5 | 0.090 |
Why?
|
| Economic Development | 1 | 2011 | 2 | 0.090 |
Why?
|
| History, 18th Century | 1 | 2011 | 7 | 0.090 |
Why?
|
| Government Agencies | 1 | 2011 | 9 | 0.090 |
Why?
|
| DNA, Bacterial | 2 | 2011 | 207 | 0.090 |
Why?
|
| Relief Work | 1 | 2011 | 7 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2011 | 26 | 0.090 |
Why?
|
| Acinonyx | 1 | 2011 | 2 | 0.090 |
Why?
|
| Fallopian Tubes | 2 | 2013 | 19 | 0.090 |
Why?
|
| Ursidae | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bees | 2 | 2022 | 17 | 0.090 |
Why?
|
| User-Computer Interface | 2 | 2021 | 74 | 0.090 |
Why?
|
| Macaca | 1 | 2011 | 36 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2012 | 62 | 0.090 |
Why?
|
| Lipase | 1 | 2011 | 18 | 0.090 |
Why?
|
| Enterocytes | 1 | 2011 | 4 | 0.090 |
Why?
|
| Ileum | 1 | 2011 | 16 | 0.090 |
Why?
|
| Survival Analysis | 3 | 2019 | 362 | 0.090 |
Why?
|
| Cricetinae | 3 | 2025 | 241 | 0.090 |
Why?
|
| Hypothalamic Hormones | 2 | 2001 | 2 | 0.090 |
Why?
|
| Escherichia coli O157 | 1 | 2011 | 17 | 0.090 |
Why?
|
| Francisella | 1 | 2011 | 20 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 114 | 0.090 |
Why?
|
| Algorithms | 1 | 2014 | 508 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 96 | 0.090 |
Why?
|
| Kidney Glomerulus | 1 | 2011 | 85 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2011 | 95 | 0.090 |
Why?
|
| Guinea Pigs | 3 | 2016 | 144 | 0.080 |
Why?
|
| China | 1 | 2011 | 233 | 0.080 |
Why?
|
| Seizures | 2 | 2022 | 79 | 0.080 |
Why?
|
| Ligands | 4 | 2005 | 387 | 0.080 |
Why?
|
| Colony Count, Microbial | 4 | 2014 | 67 | 0.080 |
Why?
|
| Immunization, Passive | 2 | 2022 | 19 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2023 | 1420 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2010 | 97 | 0.080 |
Why?
|
| Curcumin | 1 | 2011 | 115 | 0.080 |
Why?
|
| Genetic Complementation Test | 2 | 2025 | 57 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2011 | 170 | 0.080 |
Why?
|
| Gastric Mucosa | 2 | 2021 | 64 | 0.080 |
Why?
|
| Yersinia pestis | 2 | 2000 | 35 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 44 | 0.080 |
Why?
|
| Calcium | 6 | 2002 | 487 | 0.080 |
Why?
|
| Lymphocytes | 4 | 2017 | 124 | 0.080 |
Why?
|
| Antigens, Viral | 2 | 2019 | 50 | 0.080 |
Why?
|
| Hyperplasia | 2 | 2019 | 39 | 0.070 |
Why?
|
| Drosophila | 2 | 2020 | 150 | 0.070 |
Why?
|
| Immunity | 2 | 2021 | 60 | 0.070 |
Why?
|
| Immunity, Mucosal | 3 | 2017 | 52 | 0.070 |
Why?
|
| Research Design | 2 | 2022 | 370 | 0.070 |
Why?
|
| Genomics | 2 | 2021 | 289 | 0.070 |
Why?
|
| Molecular Imprinting | 1 | 2008 | 2 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 118 | 0.070 |
Why?
|
| PC12 Cells | 2 | 1998 | 93 | 0.070 |
Why?
|
| Age Factors | 3 | 2019 | 1139 | 0.070 |
Why?
|
| Enzymes | 1 | 2008 | 34 | 0.070 |
Why?
|
| Open Reading Frames | 2 | 2012 | 81 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 602 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 140 | 0.070 |
Why?
|
| Chemokines | 2 | 2021 | 97 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2018 | 168 | 0.070 |
Why?
|
| Biopsy | 2 | 2018 | 176 | 0.070 |
Why?
|
| Aptamers, Nucleotide | 1 | 2008 | 51 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 378 | 0.070 |
Why?
|
| Stomach | 2 | 2017 | 50 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 577 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 744 | 0.060 |
Why?
|
| Fluorescence | 3 | 2014 | 113 | 0.060 |
Why?
|
| Cyclic AMP | 3 | 2002 | 135 | 0.060 |
Why?
|
| Administration, Intranasal | 3 | 2014 | 89 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2007 | 90 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2018 | 206 | 0.060 |
Why?
|
| Organ Preservation Solutions | 1 | 2005 | 1 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 29 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 236 | 0.060 |
Why?
|
| Oligopeptides | 2 | 2010 | 108 | 0.060 |
Why?
|
| Vagina | 3 | 2013 | 89 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2007 | 317 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 19 | 0.060 |
Why?
|
| DNA Polymerase I | 1 | 2025 | 5 | 0.060 |
Why?
|
| Aged | 2 | 2024 | 7982 | 0.060 |
Why?
|
| DNA, Kinetoplast | 1 | 2025 | 4 | 0.060 |
Why?
|
| Vaccines, Synthetic | 3 | 2010 | 78 | 0.060 |
Why?
|
| Tetracycline | 1 | 2025 | 17 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2016 | 181 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 2025 | 22 | 0.060 |
Why?
|
| Osteoclasts | 1 | 2025 | 28 | 0.060 |
Why?
|
| Genes, Immunoglobulin Light Chain | 1 | 2024 | 2 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2025 | 44 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 2 | 2002 | 12 | 0.060 |
Why?
|
| Seoul virus | 1 | 2024 | 2 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2024 | 5 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2019 | 158 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2025 | 57 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 151 | 0.060 |
Why?
|
| Indonesia | 1 | 2024 | 22 | 0.060 |
Why?
|
| Disease Reservoirs | 1 | 2024 | 24 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2024 | 12 | 0.060 |
Why?
|
| Rodent Diseases | 1 | 2024 | 13 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2024 | 20 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2025 | 188 | 0.060 |
Why?
|
| Janus Kinases | 1 | 2024 | 22 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2012 | 273 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 1597 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2024 | 73 | 0.050 |
Why?
|
| Computational Biology | 2 | 2021 | 324 | 0.050 |
Why?
|
| Spinal Diseases | 1 | 2024 | 24 | 0.050 |
Why?
|
| STAT5 Transcription Factor | 1 | 2024 | 48 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2025 | 137 | 0.050 |
Why?
|
| Receptors, Neuropeptide | 2 | 2001 | 6 | 0.050 |
Why?
|
| Collagen | 1 | 2025 | 178 | 0.050 |
Why?
|
| Intestinal Diseases | 1 | 2023 | 6 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 34 | 0.050 |
Why?
|
| Proviruses | 1 | 2023 | 35 | 0.050 |
Why?
|
| Interleukins | 1 | 2023 | 37 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 295 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2016 | 52 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2025 | 196 | 0.050 |
Why?
|
| Hela Cells | 2 | 2014 | 370 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2023 | 139 | 0.050 |
Why?
|
| Tokyo | 1 | 2022 | 4 | 0.050 |
Why?
|
| Species Specificity | 2 | 2014 | 279 | 0.050 |
Why?
|
| Viral Load | 1 | 2024 | 344 | 0.050 |
Why?
|
| Pyridoxal Phosphate | 1 | 2002 | 11 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 246 | 0.050 |
Why?
|
| Alopecia | 1 | 2022 | 10 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2002 | 21 | 0.050 |
Why?
|
| Hair | 1 | 2022 | 38 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2023 | 131 | 0.050 |
Why?
|
| Philippines | 1 | 2022 | 80 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2022 | 57 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 66 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 75 | 0.050 |
Why?
|
| Uridine Diphosphate Glucose | 1 | 2001 | 2 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2021 | 8 | 0.050 |
Why?
|
| Systems Integration | 1 | 2021 | 16 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 221 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2001 | 68 | 0.050 |
Why?
|
| Workflow | 1 | 2021 | 23 | 0.050 |
Why?
|
| Presenilins | 1 | 2021 | 7 | 0.050 |
Why?
|
| Data Mining | 1 | 2021 | 30 | 0.050 |
Why?
|
| Calibration | 1 | 2021 | 62 | 0.050 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2021 | 32 | 0.050 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2001 | 9 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 55 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2022 | 135 | 0.040 |
Why?
|
| Taiwan | 1 | 2021 | 21 | 0.040 |
Why?
|
| Genome | 1 | 2022 | 149 | 0.040 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 2001 | 1 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 2001 | 7 | 0.040 |
Why?
|
| Fasting | 1 | 2001 | 56 | 0.040 |
Why?
|
| Walruses | 1 | 2021 | 2 | 0.040 |
Why?
|
| Phoca | 1 | 2021 | 6 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 297 | 0.040 |
Why?
|
| Data Collection | 1 | 2021 | 210 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 8 | 0.040 |
Why?
|
| Melanins | 1 | 2001 | 42 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2001 | 72 | 0.040 |
Why?
|
| Splenic Neoplasms | 1 | 2020 | 2 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 48 | 0.040 |
Why?
|
| Leukocytes | 1 | 2001 | 79 | 0.040 |
Why?
|
| Inositol Phosphates | 1 | 2000 | 8 | 0.040 |
Why?
|
| Virion | 1 | 2020 | 73 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2021 | 115 | 0.040 |
Why?
|
| Amygdala | 1 | 2021 | 125 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 170 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 121 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2020 | 47 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2012 | 462 | 0.040 |
Why?
|
| Cell Death | 2 | 2012 | 277 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2020 | 74 | 0.040 |
Why?
|
| Nervous System | 1 | 2020 | 33 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 285 | 0.040 |
Why?
|
| Arachidonic Acids | 1 | 2000 | 25 | 0.040 |
Why?
|
| Skin Diseases, Viral | 1 | 2019 | 1 | 0.040 |
Why?
|
| Urotensins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Tremor | 1 | 2019 | 9 | 0.040 |
Why?
|
| Olfaction Disorders | 1 | 2019 | 10 | 0.040 |
Why?
|
| Gallstones | 1 | 2019 | 8 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 295 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 2000 | 57 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 42 | 0.040 |
Why?
|
| Gait | 1 | 2019 | 26 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2021 | 208 | 0.040 |
Why?
|
| Posture | 1 | 2019 | 61 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 126 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2020 | 207 | 0.040 |
Why?
|
| Prednisolone | 1 | 2019 | 16 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 31 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2019 | 15 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2019 | 61 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 108 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 1737 | 0.040 |
Why?
|
| Tongue | 1 | 2019 | 14 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2019 | 39 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 30 | 0.040 |
Why?
|
| Protein Binding | 2 | 2013 | 1076 | 0.040 |
Why?
|
| Cannabinoids | 1 | 2000 | 67 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 44 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 2019 | 20 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2023 | 722 | 0.040 |
Why?
|
| Keratin-18 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Keratin-8 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Keratin-19 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Body Weight | 1 | 2020 | 428 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2019 | 198 | 0.040 |
Why?
|
| RNA | 1 | 2020 | 266 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 1729 | 0.040 |
Why?
|
| Keratin-20 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Keratin-7 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Neprilysin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 1998 | 69 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2018 | 20 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1998 | 44 | 0.040 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2018 | 5 | 0.040 |
Why?
|
| Copper | 1 | 2019 | 134 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2018 | 17 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.040 |
Why?
|
| Ammonium Sulfate | 1 | 1997 | 4 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 13 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 34 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 1997 | 10 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 1997 | 30 | 0.030 |
Why?
|
| Trypsin | 1 | 1997 | 40 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2018 | 134 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 415 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 129 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 796 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 55 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2018 | 78 | 0.030 |
Why?
|
| Cadherins | 1 | 2018 | 102 | 0.030 |
Why?
|
| Cell Count | 1 | 1997 | 140 | 0.030 |
Why?
|
| Eosinophils | 1 | 2017 | 22 | 0.030 |
Why?
|
| Reed-Sternberg Cells | 1 | 2017 | 1 | 0.030 |
Why?
|
| Gastritis | 1 | 2017 | 13 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 1997 | 79 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2017 | 21 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 249 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2017 | 20 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 661 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 97 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 2 | 2009 | 117 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 165 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 506 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 184 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 2011 | 64 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 366 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 94 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 87 | 0.030 |
Why?
|
| Lyme Disease | 1 | 2017 | 25 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 448 | 0.030 |
Why?
|
| Polyamines | 1 | 2017 | 32 | 0.030 |
Why?
|
| Monocytes | 2 | 2014 | 275 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 9 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2021 | 467 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2016 | 59 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 201 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2016 | 5 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 278 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2016 | 5 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2016 | 15 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 61 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 244 | 0.030 |
Why?
|
| Cell Communication | 1 | 2016 | 110 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 28 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 23 | 0.030 |
Why?
|
| Pneumocystis carinii | 1 | 2015 | 2 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2015 | 53 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2015 | 21 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 42 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2015 | 30 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 979 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 158 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 381 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2014 | 23 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1266 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 74 | 0.030 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2014 | 3 | 0.030 |
Why?
|
| Body Fluids | 1 | 2014 | 18 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 22 | 0.030 |
Why?
|
| Chlamydia | 1 | 2014 | 45 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 708 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2017 | 429 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2014 | 46 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 436 | 0.030 |
Why?
|
| Peroxidase | 1 | 2014 | 57 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 1994 | 11 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 1994 | 11 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 122 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 599 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2013 | 45 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1574 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 132 | 0.030 |
Why?
|
| Mitochondria | 1 | 1997 | 516 | 0.030 |
Why?
|
| Gene Library | 1 | 2013 | 60 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 411 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 24 | 0.030 |
Why?
|
| Bacterial Shedding | 1 | 2013 | 3 | 0.030 |
Why?
|
| Microfluidics | 1 | 2013 | 45 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2013 | 75 | 0.020 |
Why?
|
| Light | 1 | 1994 | 182 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 17 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2012 | 5 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3077 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 27 | 0.020 |
Why?
|
| Myocardium | 1 | 2014 | 251 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 2012 | 14 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 20 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 204 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 256 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 12 | 0.020 |
Why?
|
| Cryoglobulins | 1 | 2011 | 1 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 2011 | 2 | 0.020 |
Why?
|
| Parasite Egg Count | 1 | 2011 | 5 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2011 | 9 | 0.020 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2011 | 6 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 71 | 0.020 |
Why?
|
| Complement C3 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 43 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 149 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 3942 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 64 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 934 | 0.020 |
Why?
|
| Asthma | 1 | 2016 | 410 | 0.020 |
Why?
|
| Polymyxin B | 1 | 2011 | 8 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 90 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 54 | 0.020 |
Why?
|
| DNA Probes | 2 | 2001 | 33 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 181 | 0.020 |
Why?
|
| Mammals | 1 | 2011 | 109 | 0.020 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2010 | 14 | 0.020 |
Why?
|
| Organelles | 1 | 2010 | 21 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 33 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 37 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 352 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2010 | 14 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 2000 | 107 | 0.020 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2010 | 5 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 16 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 118 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2010 | 41 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2001 | 195 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 293 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 303 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2010 | 141 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 457 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1848 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 54 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2006 | 34 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 640 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 2002 | 7 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2002 | 4 | 0.010 |
Why?
|
| Thionucleotides | 1 | 2002 | 8 | 0.010 |
Why?
|
| Suramin | 1 | 2002 | 4 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 77 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 136 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2001 | 8 | 0.010 |
Why?
|
| Cyclophilins | 1 | 2001 | 10 | 0.010 |
Why?
|
| Nephropidae | 1 | 2001 | 1 | 0.010 |
Why?
|
| Sea Anemones | 1 | 2001 | 3 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 2001 | 60 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 139 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 123 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 61 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 141 | 0.010 |
Why?
|
| Prolactin-Releasing Hormone | 1 | 2000 | 1 | 0.010 |
Why?
|
| Actins | 1 | 2001 | 162 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 39 | 0.010 |
Why?
|
| FMRFamide | 1 | 2000 | 12 | 0.010 |
Why?
|
| Arrestins | 1 | 2000 | 28 | 0.010 |
Why?
|
| Threshold Limit Values | 1 | 2000 | 2 | 0.010 |
Why?
|
| Bacteriocins | 1 | 2000 | 7 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 400 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 113 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2001 | 108 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 2000 | 2 | 0.010 |
Why?
|
| Ethanolamines | 1 | 2000 | 9 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2000 | 15 | 0.010 |
Why?
|
| Melanoma | 1 | 2001 | 109 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2000 | 24 | 0.010 |
Why?
|
| Capsaicin | 1 | 2000 | 28 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1999 | 4 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 146 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 138 | 0.010 |
Why?
|
| Endocannabinoids | 1 | 2000 | 40 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2000 | 228 | 0.010 |
Why?
|
| Amides | 1 | 2000 | 72 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 222 | 0.010 |
Why?
|
| Linear Models | 1 | 2000 | 311 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 230 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2001 | 633 | 0.010 |
Why?
|
| Pregnancy | 1 | 2001 | 1737 | 0.010 |
Why?
|
| Quartz | 1 | 1994 | 3 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1994 | 25 | 0.010 |
Why?
|